Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer

Abstract Background Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enu...

Full description

Bibliographic Details
Main Authors: Stephanie N. Shishido, Anders Carlsson, Jorge Nieva, Kelly Bethel, James B. Hicks, Lyudmila Bazhenova, Peter Kuhn
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Journal of Translational Medicine
Subjects:
Non-small cell lung cancer
Circulating tumor cells
HD-SCA
Liquid biopsy
Online Access:http://link.springer.com/article/10.1186/s12967-019-2035-8

Internet

http://link.springer.com/article/10.1186/s12967-019-2035-8

Similar Items